CVS Health Q4 Net Income Soars to $2.94B, Cuts FY26 Cash Flow Forecast
CVS Health’s fourth-quarter net income rose to $2.943 billion ($2.30 per share) from $1.644 billion ($1.30) a year ago, and revenues exceeded analyst estimates. The company trimmed its FY26 operating cash flow guidance to at least $9.0 billion from $10.0 billion while reaffirming EPS forecasts of $5.94–$6.14 ($7.00–$7.20 adjusted).
1. Q4 Earnings Beat Estimates
In the fourth quarter, CVS Health reported net income of $2.943 billion ($2.30 per share) versus $1.644 billion ($1.30) a year earlier, topping consensus estimates, and revenue surpassed market forecasts.
2. Cash Flow Guidance Trimmed
The company reduced its fiscal 2026 operating cash flow guidance to at least $9.0 billion from the prior floor of $10.0 billion, reflecting more conservative expectations for cash generation.
3. FY26 Earnings Outlook Confirmed
CVS Health reaffirmed its FY26 EPS guidance of $5.94–$6.14 and adjusted EPS of $7.00–$7.20, and maintained its full-year revenue target of at least $400.0 billion along with operating income and adjusted operating income ranges.
4. Stock Reaction
In pre-market trading, shares fell about 3.9%, trading near $72.85 as investors weighed the beat on earnings against the lowered cash flow projection.